Estimation of an Appropriate Human Dose of Boesenbergia pandurata Extracts Based on Allometric Scaling Data of Panduratin A in Mice, Rats, and Dogs
- 1 April 2020
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Medicinal Food
- Vol. 23 (4), 453-458
- https://doi.org/10.1089/jmf.2019.4564
Abstract
It can be difficult to identify health/functional foods that exert therapeutic benefits for alleviating gingivitis and periodontitis. Recently, extracts of Boesenbergia pandurata (Roxb.), which is a tropical plant, have shown promising inhibitory activity against lipopolysaccharide-induced periodontitis. As a result, a clinical trial is being planned to assess utility of B. pandurata (Roxb.) extracts for promoting oral health; this study was designed to determine an appropriate human dose of the extracts for the trial. Pharmacokinetic studies of panduratin A, which is an active substance in fingerroot, were carried out in mice, rats, and dogs after oral administration of the extracts. The clearance data for each species were used to estimate clearance in humans through allometric scaling based on the maximum lifespan potential, and a daily dose providing sufficient anti-periodontitis activity was estimated for use in the clinical trial. The findings indicated that allometric scaling is a reasonable approach that is relatively free of safety issues and can be used to determine doses of substances for incorporation into health/functional foods appropriate for humans.Keywords
This publication has 26 references indexed in Scilit:
- Inhibitory Effects of Standardized Boesenbergia pandurata Extract and Its Active Compound Panduratin A on Lipopolysaccharide-Induced Periodontal Inflammation and Alveolar Bone Loss in RatsJournal of Medicinal Food, 2018
- Oral intake of Boesenbergia pandurata extract improves skin hydration, gloss, and wrinkling: A randomized, double‐blind, and placebo‐controlled studyJournal of Cosmetic Dermatology, 2017
- Antiviral potential of 4-hydroxypanduratin A, secondary metabolite of Fingerroot, Boesenbergia pandurata (Schult.), towards Japanese Encephalitis virus NS2B/NS3 proteBioinformation, 2013
- Therapeutic potential of panduratin A, LKB1-dependent AMP-activated protein kinase stimulator, with activation of PPARα/δ for the treatment of obesityDiabetes, Obesity and Metabolism, 2011
- In Vitro Activities of Panduratin A against Clinical Staphylococcus StrainsAntimicrobial Agents and Chemotherapy, 2009
- Anti-inflammatory effects of compounds from Kaempferia parviflora and Boesenbergia pandurataFood Chemistry, 2009
- Isopanduratin A from Kaempferia pandurata as an active antibacterial agent against cariogenic Streptococcus mutansInternational Journal of Antimicrobial Agents, 2004
- In VitroAnti-Inflammatory Activity of Panduratin A Isolated fromKaempferia panduratain RAW264.7 CellsPlanta Medica, 2003
- Anti-inflammatory cyclohexenyl chalcone derivatives in Boesenbergia pandurataPhytochemistry, 2002
- Structural Analysis of a Novel Antimutagenic Compound, 4-Hydroxypanduratin A, and the Antimutagenic Activity of Flavonoids in a Thai Spice, Fingerroot (Boesenbergia pandurata Schult.) against Mutagenic Heterocyclic AminesJournal of Agricultural and Food Chemistry, 2001